Plasma Aβ42 and Aβ40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

por Seppälä, T T, Herukka, S-K, Hänninen, T, Tervo, S, Hallikainen, M, Soininen, H, Pirttilä, T
Publicado 2010

CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease

por Paajanen, T., Hänninen, T., Aitken, A., Hallikainen, M., Westman, E., Wahlund, L.-O., Sobow, T., Mecocci, P., Tsolaki, M., Vellas, B., Muehlboeck, S., Spenger, C., Lovestone, S., Simmons, A., Soininen, H.
Publicado 2013

Metabolome in progression to Alzheimer's disease

por Orešič, M, Hyötyläinen, T, Herukka, S-K, Sysi-Aho, M, Mattila, I, Seppänan-Laakso, T, Julkunen, V, Gopalacharyulu, P V, Hallikainen, M, Koikkalainen, J, Kivipelto, M, Helisalmi, S, Lötjönen, J, Soininen, H
Publicado 2011

Multimodal Preventive Trial for Alzheimer’s Disease: MIND-ADmini Pilot Trial Study Design and Progress

por Sindi, S., Thunborg, C., Rosenberg, A., Andersen, P., Andrieu, S., Broersen, L. M., Coley, N., Couderc, C., Duval, C. Z., Faxen-Irving, G., Hagman, G., Hallikainen, M., Håkansson, K., Lehtisalo, J., Levak, N., Mangialasche, F., Pantel, J., Kekkonen, E., Rydström, A., Stigsdotter-Neely, A., Wimo, A., Ngandu, T., Soininen, H., Hartmann, T., Solomon, A., Kivipelto, Miia
Publicado 2022